Postherpetic neuralgia (phn) market to reach $1.06 billion by 2030 at 6.5% cagr, driven by increasing prevalence of chronic pain conditions linked to aging populations and degenerative diseases.
Read More
Portable bioprocessing bioreactors market to reach $5.03 billion by 2030 at 12.3% cagr, driven by growing demand for gene therapies enabled by advances in genetic sequencing.
Read More
Porcine gelatin market to reach $1.47 billion by 2030 at 6.2% cagr, driven by rising use of dietary supplements supported by growing consumer focus on preventive health and wellness.
Read More
Porcine epidemic diarrhea vaccines market to reach $2.5 billion by 2030 at 6.7% cagr, driven by increasing pig farming supported by rising global demand for pork.
Read More
Pontine glioma drugs market to reach $1.74 billion by 2030 at 9.8% CAGR, driven by rising demand for personalized medicine.
Read More
Polydeoxyribonucleotide (pdrn) repair ampoule market to reach $0.86 billion by 2030 at 12.4% CAGR, driven by increasing demand for non-surgical aesthetic procedures.
Read More
Polyclonal antibodies market to reach $2.1 billion by 2030 at 7.3% CAGR, driven by increasing prevalence of cancer.
Read More
Point of care connectivity solutions market to reach $2.13 billion by 2030 at 9.8% CAGR, driven by rising prevalence of diabetes.
Read More
Pneumococcal vaccine market to reach $12.76 billion by 2030 at 6.5% CAGR, driven by increasing prevalence of pneumococcal contamination.
Read More
Pms and menstrual health supplements market to reach $40.39 billion by 2030 at 8.1% CAGR, driven by increasing prevalence of polycystic ovary syndrome (pcos).
Read More